HIL to commercialise VCRC Bti bio-larvicide technology for mosquito vector control programs
HIL has set up the Bti bio-larvicide manufacturing facility at its Rasayani Plant at Maharashtra with the financial assistance of GEF/UNIDO under the project
HIL has set up the Bti bio-larvicide manufacturing facility at its Rasayani Plant at Maharashtra with the financial assistance of GEF/UNIDO under the project
By applying digital technologies, pharma companies can significantly improve their operational and decision-making capabilities
The array available for a subscription includes popular products to make menstrual hygiene a regular practice and extend further affordability to its users
Bringing next-gen cannabinoid therapeutics to cancer patients
Agreement to co-develop artificial intelligence (AI) technology for the application in peptide drug design
Revenues from operations for the full year ended March 31, 2022 stood at Rs. 590.05 crore as compared to Rs. 449.82 crore in FY21
Large datasets will train machine learning models and speed up agile discovery of novel crop protection solutions
The three-year collaboration will focus on the development of new tools for computational chemistry modelling as well as new molecular representations to advance the next generation of molecular machine learning
Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years.
RH Capital, a leading women's health venture capital fund, announced three new investments to improve health outcomes for women in the US.
Subscribe To Our Newsletter & Stay Updated